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proteins (Figure 1A). Considering the
significant differences between the
methods used, and the analysis of distinct
hESC lines between studies, the 35%
overlap detected seems to be of some
significance, and in line with previous
comparisons (Olsen et al., 2006). At the
same time, given the different methods
of differentiation utilized by the two
groups, the fact that BMP4 induction
promotes extraembryonic lineages (Xu
et al., 2002; Pera et al., 2004) whereas ret-
inoic acid directs hESCs toward an ecto-
derm cell fate (Wichterle et al., 2002),
and differing time points examined in
each case, it should not be surprising
that we see much less overlap (7%)
between the two differentiated data sets
(Figure 1B). However, it is interesting to
note that a significant number of protein
synthesis and translation regulators are
found differentially phosphorylated within
only 240 min of differentiation (a majority
within as few as 30 min) (Figure 1B). This
pattern implies that FGF removal and/or
addition of BMP4 also regulate the cell
at the translational level in addition to the
transcriptional level.
Needless to say, both papers provide
a substantial amount of data that stem
cell scientists can mine for the purpose
of developing new hypotheses. These
models can then be tested for their
potential roles in the control of the undif-
ferentiated state or in the initial steps of
differentiation. Brill et al. (2009) undertake
this approach by identifying additional
receptor tyrosine kinases activated in
hESCs and, in doing so, reveal an effect
of PDGF in the maintenance of pluripo-
tency. Meanwhile, Van Hoof et al. (2009)
identify a phosphorylation site on Sox2
that mediates SUMOylation, potentially
providing a mechanism to overcome the
stem cell regulatory circuitry during the
initial phase of differentiation.
Many of the phosphorylation sites
identified in these studies remain unchar-
acterized, and their functions unknown,
and yet describing these data sets is
only an initial step in characterizing the
hESC phosphoproteome, given that Swa-
ney et al. (2009) have recently identified
thousands more sites. Ultimately these
types of studies will provide sufficient
phosphoproteome resources to allow
the stem cell community to integrate
cellular regulation at all levels of control
and achieve mastery over the hESC and
its fate choices. It may be a daunting
task, but it is exciting to see the progress
made thus far.
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Although CD95 (Fas/Apo-1) has long been known to be broadly expressed in the brain, its function has
remained enigmatic. In this issue ofCell StemCell, Corsini et al. (2009) now show that CD95 serves as a potent
activator of neurogenesis in both the healthy and injured brain.CD95 is the best characterized and para-
digmatic member of the TNF-receptor
superfamily of ‘‘death receptors,’’ and the
molecular mechanism of CD95-induced
apoptosis is known specifically. After
bindingofCD95L,CD95 forms trimers and
sequentially recruits the adaptor protein
FADD, regulatory proteins (like DAXX or128 Cell Stem Cell 5, August 7, 2009 ª2009FLIP), and procaspase 8, leading to the
formation of a death-inducing complex
(DISC). The oligomerization then results
in the autoproteolytic cleavage of procas-
pase 8 and the initiation of the apoptotic
cascade (Peter and Krammer, 2003). In
the central nervous system, CD95 expres-
sion varies significantly during develop-Elsevier Inc.ment. In the adult brain, neurons in the
hippocampus and cerebral cortex show
the highest CD95 expression, although
CD95 expression is also detectable on
astrocytes and oligodendrocytes espe-
cially under pathological conditions. Con-
versely, the cognate ligand CD95L is
constitutively coexpressed on neurons
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Previewsand perivascular astrocytes
of the healthy brain and upre-
gulated by ischemia and in-
flammation. Mice with defec-
tive CD95 receptor signaling
perform better and develop
smaller lesions compared
with their wild-type littermates
in several models of acute
brain damage including
stroke, multiple sclerosis,
and trauma, and such a result
is consistent with CD95
receptor signaling’s role in
apoptosis (Reich et al., 2008).
The well-established proa-
poptotic effect of CD95 raises
the intriguing question why
CD95 is also constitutively ex-
pressed by neurons in the
healthy brain. A lifelong ex-
pression just to kill neurons
once a stroke happens ap-
pears rather unlikely. In addi-
tion, a detailed analysis of
CD95-deficient mice showed
significantly impaired spatial
learning of healthy and injured animals,
suggesting more complex roles for CD95
signaling in the adult brain (Reich et al.,
2008; Sakic et al., 1997). In two recent
papers, Ana Martin-Villalba’s group has
now investigated the physiological func-
tion of CD95 in the brain apart from
inducing apoptosis. Their studies reveal
that CD95 can potently mediate neurore-
generation by both inducing dendrite
branching of mature neurons (Zuliani
et al., 2006) and by activating adult neuro-
genesis (Corsini et al., 2009).
Corsini et al. (2009) report that CD95
promotes neurogenesis and favors neu-
ronal differentiation at the neural stem
cell (NSC) level but does not induce
apoptosis in this issue of Cell Stem
Cell. On a functional level, experimental
suppression of CD95-mediated neuro-
genesis in the hippocampus resulted in
reduced spatial learning of untreated
animals and impaired integration of
injected NSCs into the hippocampus in
a mouse model of global ischemia. Inter-
estingly, the data presented suggests
that CD95 expression is restricted on
the stem cell fraction within the subven-
tricular zone (SVZ). This high specificity
may even allow the use of CD95 as NSC-
specific marker and implies a distinct
proneurogenic function of CD95L/CD95
interactions within the stem cell niche. A
comparative analysis will help to integrate
the CD95/CD95L system with other
molecular signaling cascades such as
EGF or BMP that are also known to regu-
late neurogenesis in the SVZ.
In the present work, Corsini et al. (2009)
have identified some of the components
of the intracellular signaling cascade
necessary for CD95-mediated neurogen-
esis (see Figure 1). In NSCs, activation of
CD95 by CD95L induced the recruitment
of the scr-familiy kinase member
pp60-src and the activation of the PI-3
kinase/AKT signaling pathway. Notably,
this signaling pathway was found to occur
in the absence of formation of the
apoptotic DISC and also did not require
the recruitment of the adaptor protein
FADD. The promotion of neurogenesis
further required the phosphorylation and
the subsequent activation of two addi-
tional downstream proteins: GSK3b and
mTOR. The intracellular signaling via
PI-3 kinase/AKT differs from a previously
described CD95-meditated neuronal
branching pathway that requires the
activation of the ERK-p35 signaling
pathway but was also found to be inde-
pendent of the recruitment of FADD and
the activation of caspases (Desbarats
et al., 2003).
The spectrum of different
CD95-activated apoptotic
and nonapoptotic intracellu-
lar signaling cascades in
different neural populations
and different stages of
neurogenesis demonstrates
the biological importance of
a tight regulation of CD95
during each neuron’s life.
CD95-associated regulatory
proteins like PEA-1, Rac1,
c-FLIP, and FAF1 and the
neuron-specific group of
FAIM proteins including
FAIM1 (short/long) and FAIM2
(LFG/NMP35) play a major
but only partially characterized
role in regulating the respon-
siveness of NSC, neuroblasts,
and neurons toward CD95L-
mediated apoptotic and non-
apoptotic signaling (Beier
et al., 2005; Reich et al.,
2008). It will be exciting to
understand how these pro-
teins guide CD95 to induce
cell death, neurogenesis, or neurite out-
growth. The work by Corsini et al. (2009)
now provides the starting point for addi-
tional in-depth investigation of this intracel-
lular network at all stages of neurogenesis.
The work from Martin-Villalbas group
on the context-dependent functions of
CD95 also has possible implications
for the genesis of glioblastoma cancer
stem cells (CSCs, also referred to as glio-
blastoma-initiating cells) that probably
derive from NSC (Sanai et al., 2005). In
contrast to its proapoptotic function in
postmitotic neurons, CD95-mediated
nonapoptotic signaling in NSCs may
even bear oncogenic potential (Corsini
et al., 2009). Mutations in the CD95
signaling pathway resulting in deregulated
proliferation of NSC because of an
increased proportion of asymmetrical
cell divisions of NSCs and a decreased
neuronal differentiation after activation
of CD95 could potentially result in (pre-)
cancerous lesions and may thus be
involved in the transition of NSCs into glio-
blastoma CSCs. In this case, the function
of CD95 may not switch from ‘‘neuro-
genic’’ toward ‘‘apoptotic’’ but toward
‘‘oncogenic.’’ In line with this idea, the
promigratory function of CD95 on glioma
cells was only recently discovered by the
same group (Kleber et al., 2008).
Figure 1. Differential Function of CD95 during Neurogenesis
The figure shows the known and postulated functions of CD95 during neuro-
genesis and gives an overview over the respective intracellular signaling path-
ways identified so far.Cell Stem Cell 5, August 7, 2009 ª2009 Elsevier Inc. 129
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of CD95 in brain and in glioblastoma
(Kleber et al., 2008; Martin-Villalba et al.,
1999), the group of Ana Martin-Villalba
has now provided evidence that CD95 is
not just a killer but can also be beneficial
for brain repair (Corsini et al., 2009; Zuliani
et al., 2006). Thus, targeting CD95-medi-
ated neurogenesis could potentially be
a useful strategy for the treatment of
a wide range of neurological diseases.
However, the three-faceted role of CD95
in the brain also makes this receptor a
dangerous therapeutic target. Taken
together, the recent body of work on the
complex role of CD95 in the brain
suggests that, the intracellular regulatory
network of CD95 may be instrumental in
regulating whether CD95 will act to stimu-
late proapoptotic, proneurogenic, or even
protumorigenic signaling pathways. Addi-Smooth(ing) Musc
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In a recent report in Nature, Co
smooth muscle cell (SMC) plastic
determination.
Recent studies have established micro-
RNAs (miRNAs) as a class of critical medi-
ators involved in the regulation of cell
proliferation and differentiation in cardiac
(van Rooij et al., 2007; Zhao et al., 2007),
skeletal (Chen et al., 2006), and smooth
(Cheng et al., 2009) muscles. In addition,
miRNAs have also been demonstrated to
play a role in the maintenance of embry-
onic stemcell (ESC) pluripotency (Xuet al.,
2009). Cordes et al. (2009) now link the
function of miRNAs to smooth muscle cell
(SMC) fate determination and plasticity
by showing that miR-143 and miR-145
regulate the proliferation and differentia-
tion of vascular SMCs.
During the early embryonic stages of
vasculogenesis, SMCs and their progeni-
130 Cell Stem Cell 5, August 7, 2009 ª2009tional work to further elucidate the regula-
tory network of CD95 will thus be needed
to identify specific targets downstream of
CD95 that will serve to direct the CD95
inducing signal specifically along neurore-
generative pathways while bypassing
apoptosis.
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However, in adult blood vessels, SMCs
become quiescent and express a reper-
toire of contractile, calcium regulatory,
and signal transduction proteins neces-
sary for the contractile function of fully
differentiated SMCs (Owens et al., 2004).
Further, SMCs, unlike cardiac and skel-
etal myocytes, are not terminally differen-
tiated and are capable of regaining their
highly proliferative and migratory charac-
teristics under certain conditions such as
vascular injury. Expression of nearly all
SMC marker genes is known to be
dependent upon one or more serum
response elements (SRE, CC(AT)6GG
or CArG boxes) in their promoters/
enhancers. Serum response factor (SRF)
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miR-143 and miR-145 modulate
tion factors involved in SMC fate
is known to regulate growth response
genes as well as muscle-specific genes
through its interaction with the muscle
cell-enriched SRF cofactor myocardin
(Wang et al., 2001). Further, it is well
documented that SRF cofactors, many
of which are antagonistic in action, are
mechanistically involved in regulating
phenotypic switching of SMCs between
proliferation and differentiation, thus
providing a molecular explanation of cell
fate maintenance and change at the tran-
scriptional level (Owens et al., 2004;
Wang et al., 2004). However, the func-
tional significance of miRNAs during
SMC differentiation remains uncertain. In
particular, whether a specific miRNA is
both necessary and sufficient to induce
